(Q37582928)

21 August 2017

Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children (English)

1 reference

21 August 2017

Steven Hunt

7

0 references

Rachel Schneerson

8

object named as

Rachel Schneerson

1 reference

21 August 2017

11

Joseph Shiloach

1 reference

21 August 2017

Do Gia Canh

1

1 reference

21 August 2017

Feng-ying Kimi Lin

2

1 reference

21 August 2017

Vu Dinh Thiem

3

1 reference

21 August 2017

Dang Duc Trach

4

1 reference

21 August 2017

Nguyen Dinh Trong

5

1 reference

21 August 2017

Nguyen Duc Mao

6

1 reference

21 August 2017

John B Robbins

9

1 reference

21 August 2017

Chiayung Chu

10

1 reference

21 August 2017

Dolores A Bryla

12

1 reference

21 August 2017

Marie-Claude Bonnet

13

1 reference

21 August 2017

Dominique Schulz

14

1 reference

21 August 2017

Shousun C Szu

15

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

21 August 2017

Infection and Immunity

1 reference

21 August 2017

72

1 reference

21 August 2017

11

1 reference

21 August 2017

6586-6588

1 reference

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=523060

Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15501790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15501790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pneumococcal conjugate vaccines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15501790

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/IAI.72.11.6586-6588.2004

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

15501790

1 reference